ESTRELLA IMMUNOPHARMA INC (ESLA) Stock Income Statement
NASDAQ:ESLA - Nasdaq - US2975841048 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 10.48M | 7.31M | 11.11M | 1.69M | 250.00K | |||
| Research and Development | 7.79M | 4.11M | 10.45M | 1.39M | N/A | |||
| Selling, General, and Administrative Expenses | 2.69M | 3.20M | 663.20K | 296.30K | 70.00K | |||
| Operating Income | -10.48M | -7.31M | -11.11M | -1.69M | -250.00K | |||
| Interest Income/Expense | N/A | N/A | 650.00K | 650.00K | 0.00 | |||
| Income Before Taxes | -10.48M | -7.31M | -11.11M | -1.69M | -250.00K | |||
| Income Tax | 1.70K | 1.60K | 0.00 | 0.00 | 0.00 | |||
| Net Income | -10.48M | -7.31M | -11.11M | -1.69M | -250.00K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.28 | -0.20 | -0.32 | -0.05 | -0.21 | |||
| Statistics | ||||||||
All data in USD